- Tytuł:
- Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.
- Autorzy:
- Źródło:
- Lancet Oncology. Nov2016, Vol. 17 Issue 11, p1590-1598. 9p.
Czasopismo naukowe